Labeled for this condition

Medicines for leukemia, lymphoma and myeloma

98 medicines have an FDA label indicated for leukemia, lymphoma and myeloma; 40 are listed from generic labelers and 5 have a presentation in shortage now (FDA files, October 8, 2026).

Which medicines are labeled for leukemia, lymphoma and myeloma?

Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.

Recalls: FDA enforcement reports, 2012 on
Medicine	Brand names	Generic labelers (all forms)	Pharmacy cost	Boxed warning	Shortage	Recalls since 2012
Hydrocortisone	Solu-Cortef, Alkindi, Cortef	49 labelers	$0.0613 per gram 1% cream	No	A presentation being discontinued	7
Prednisone	none listed	45 labelers	$0.0643 per tablet 20 mg tablet	No	No current entry	10
Triamcinolone	Kenalog, Triesence, Nasacort	73 labelers	$0.0452 per gram 0.1% cream	No	Listed; available	27
Dexamethasone	Ozurdex, Maxidex, Hemady	60 labelers	$0.193 per tablet 4 mg tablet	No	In shortage	8
Methylprednisolone	Solu-Medrol, Depo-Medrol, Medrol	35 labelers	$0.121 per tablet 4 mg tablet	No	In shortage	46
Lenalidomide	Revlimid	18 labelers	n/a	Yes	No current entry	0
Dasatinib	Sprycel, Phyrago	14 labelers	$26.46 per tablet 100 mg tablet	No	No current entry	0
Betamethasone	Celestone, Sernivo, Diprolene	28 labelers	$0.418 per gram 0.05% cream	No	No current entry	13
Cyclophosphamide	Frindovyx	19 labelers	$1.67 per capsule 50 mg capsule	No	No current entry	6
Methotrexate	Rasuvo, Otrexup, Jylamvo	29 labelers	$0.158 per tablet 2.5 mg tablet	Yes	In shortage	8
Arsenic trioxide	Trisenox	16 labelers	n/a	Yes	A presentation being discontinued	0
Doxorubicin	Doxil	16 labelers	n/a	Yes	No current entry	5
Prednisolone	Orapred, Pred	25 labelers	$4.72 per mL 1% eye drop	No	No current entry	9
Imatinib	Gleevec, Imkeldi	20 labelers	$0.624 per tablet 100 mg tablet	No	No current entry	4
Pomalidomide	Pomalyst	11 labelers	n/a	Yes	No current entry	0
Bortezomib	Velcade, Boruzu	22 labelers	n/a	No	No current entry	3
Azacitidine	Onureg, Vidaza	20 labelers	n/a	No	In shortage	8
Nilotinib	Tasigna, Danziten, Cavhanza	6 labelers	n/a	Yes	No current entry	2
Hydroxyurea	Droxia, Hydrea, Siklos	10 labelers	$0.184 per capsule 500 mg capsule	No	No current entry	0
Bendamustine	Treanda, Vivimusta, Gobarden	4 labelers	n/a	No	A presentation being discontinued	1
Melphalan	Hepzato, Evomela, Ivra	13 labelers	n/a	Yes	A presentation being discontinued	0
Nelarabine	Arranon	12 labelers	n/a	Yes	No current entry	2
Carmustine	Gliadel	10 labelers	n/a	Yes	No current entry	0
Cytarabine	none listed	5 labelers	n/a	Yes	No current entry	2
Bleomycin	none listed	5 labelers	$26.45 per vial 15 unit vial	Yes	No current entry	3
Idarubicin	Idamycin	2 labelers	n/a	Yes	No current entry	1
Bosutinib	Bosulif	3 labelers	n/a	No	No current entry	0
Bexarotene	Targretin	7 labelers	n/a	Yes	No current entry	1
Busulfan	Myleran	7 labelers	n/a	Yes	A presentation being discontinued	1
Clofarabine	none listed	9 labelers	n/a	No	No current entry	1
Cladribine	Mavenclad	6 labelers	n/a	Yes	No current entry	0
Rituximab	Riabni, Ruxience, Rituxan	none listed	n/a	Yes	No current entry	1
Mercaptopurine	Purixan	2 labelers	$1.07 per tablet 50 mg tablet	No	No current entry	6
Asciminib	Scemblix	none listed	n/a	No	No current entry	0
Daunorubicin	none listed	2 labelers	n/a	Yes	No current entry	2
Fludarabine	none listed	6 labelers	n/a	Yes	No current entry	1
Ibrutinib	Imbruvica	none listed	n/a	No	No current entry	0
Pralatrexate	Folotyn	1 labeler	n/a	No	No current entry	0
Selinexor	Xpovio	none listed	n/a	No	No current entry	0
Sonrotoclax	Beqalzi	none listed	n/a	No	No current entry	0
Cortisone	none listed	1 labeler	n/a	No	No current entry	0
Mitoxantrone	none listed	3 labelers	n/a	Yes	No current entry	1
Mosunetuzumab	Lunsumio	none listed	n/a	Yes	No current entry	0
Nivolumab	Opdivo	none listed	n/a	No	No current entry	1
Ponatinib	Iclusig	none listed	n/a	Yes	No current entry	0
Thalidomide	none listed	none listed	n/a	Yes	No current entry	0
Venetoclax	Venclexta	none listed	n/a	No	No current entry	0
Acalabrutinib	Calquence	none listed	n/a	No	No current entry	0
Carfilzomib	Kyprolis	none listed	n/a	No	No current entry	2
Elranatamab	Elrexfio	none listed	n/a	Yes	No current entry	0
Isatuximab	Sarclisa	none listed	n/a	No	No current entry	0
Ixazomib	Ninlaro	none listed	n/a	No	No current entry	0
Revumenib	Revuforj	none listed	n/a	Yes	No current entry	0
Romidepsin	Istodax	2 labelers	n/a	No	No current entry	0
Alemtuzumab	Lemtrada, Campath	none listed	n/a	Yes	No current entry	0
Chlorambucil	Leukeran	none listed	n/a	Yes	No current entry	0
Daratumumab	Darzalex	none listed	n/a	No	No current entry	1
Duvelisib	Copiktra	none listed	n/a	Yes	No current entry	0
Elotuzumab	Empliciti	none listed	n/a	No	No current entry	0
Enasidenib	Idhifa	none listed	n/a	Yes	No current entry	0
Epcoritamab	Epkinly	none listed	n/a	Yes	No current entry	0
Glasdegib	Daurismo	none listed	n/a	Yes	No current entry	0
Glofitamab	Columvi	none listed	n/a	Yes	No current entry	0
Hyaluronidase and rituximab	Rituxan	none listed	n/a	Yes	No current entry	0
Iberdomide	Zenbexus	none listed	n/a	Yes	No current entry	0
Pirtobrutinib	Jaypirca	none listed	n/a	No	No current entry	0
Quizartinib	Vanflyta	none listed	n/a	Yes	No current entry	0
Tafasitamab	Monjuvi	none listed	n/a	No	No current entry	0
Talquetamab	Talvey	none listed	n/a	Yes	No current entry	0
Teclistamab	Tecvayli	none listed	n/a	Yes	No current entry	0
Thioguanine	Tabloid	none listed	n/a	No	No current entry	0
Vincristine	none listed	1 labeler	n/a	Yes	No current entry	1
Zanubrutinib	Brukinsa	none listed	n/a	No	No current entry	0
Asparaginase	Rylaze	none listed	n/a	No	No current entry	0
Belantamab mafodotin	Blenrep	none listed	n/a	Yes	No current entry	0
Belinostat	Beleodaq	none listed	n/a	No	No current entry	0
Blinatumomab	Blincyto	none listed	n/a	Yes	No current entry	0
Brentuximab vedotin	Adcetris	none listed	n/a	Yes	No current entry	0
Calaspargase	Asparlas	none listed	n/a	No	No current entry	0
Cedazuridine and decitabine	Inqovi	none listed	n/a	No	No current entry	0
Cytarabine and daunorubicin	Vyxeos	none listed	n/a	Yes	No current entry	0
Daratumumab and hyaluronidase	Darzalex	none listed	n/a	No	No current entry	0
Denileukin diftitox	Lymphir	none listed	n/a	Yes	No current entry	0
Gemtuzumab ozogamicin	Mylotarg	none listed	n/a	Yes	No current entry	0
Ibritumomab tiuxetan	Zevalin	none listed	n/a	Yes	No current entry	0
Inotuzumab ozogamicin	Besponsa	none listed	n/a	Yes	No current entry	0
Ivosidenib	Tibsovo	none listed	n/a	Yes	No current entry	0
Loncastuximab tesirine	Zynlonta	none listed	n/a	No	No current entry	0
Mechlorethamine	Valchlor	none listed	n/a	No	No current entry	0
Midostaurin	Rydapt	none listed	n/a	No	No current entry	0
Obinutuzumab	Gazyva	none listed	n/a	Yes	No current entry	0
Olutasidenib	Rezlidhia	none listed	n/a	Yes	No current entry	0
Pegaspargase	Oncaspar	none listed	n/a	No	No current entry	0
Pembrolizumab	Keytruda	none listed	n/a	No	No current entry	1
Pentostatin	Nipent	none listed	n/a	Yes	In shortage	0
Tazemetostat	Tazverik	none listed	n/a	No	A presentation being discontinued	0
Vinblastine	none listed	1 labeler	n/a	Yes	No current entry	1
Ziftomenib	Komzifti	none listed	n/a	Yes	No current entry	0

Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)

What do pharmacies pay?

Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.

Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price

What next?

Every condition
Compare two medicines